Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOsirium Tech Regulatory News (OSI)

  • This share is currently suspended. It was suspended at a price of 2.20

Share Price Information for Osirium Tech (OSI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.20
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.00
OSI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update re proposed grant of options

18 Apr 2023 07:00

RNS Number : 5049W
Osirium Technologies PLC
18 April 2023
 

18 April 2023

 

Osirium Technologies plc

("Osirium", the "Group" or the "Company")

 

Update re proposed grant of options

 

Osirium Technologies plc (AIM: OSI), a leading vendor of cloud-based cybersecurity and IT automation software, provides an update on the proposed amendments to the Company's share option scheme to be considered at its forthcoming AGM, details of which were announced on 3 April 2023 (the "Announcement").

 

The Company has received feedback from certain key shareholders in the Company ("Shareholders") regarding the proposed New Options set out in the Announcement. The Company intends to continue to seek shareholder approval for the amendments to the Company's Enterprise Management Incentive (EMI) Share Option Plan 2020-2025 (the "Plan") at the AGM as set out in the AGM notice. However, Osirium's Remuneration Committee (the "Remuneration Committee") has taken on board the feedback received and has decided to make certain amendments to the New Options proposed to be granted, should the Plan Resolution be passed at the AGM, as follows:

 

· the New Options will have a minimum exercise price of 2p (being the issue price of the Company's most recent fundraise) or, if higher at the time of grant, the 'Market Price' of an Ordinary Share as determined under the Plan rules;

 

· all New Options will be subject to the following additional performance based vesting criteria:

the closing share price of an Ordinary Share must exceed 4p for a rolling 30-day period; and

the Company must have achieved annualised recurring revenue ("ARR") of at least £3.5 million, when reported in the Company's full year or half year results.

 

· The New Options would still vest equally over three years as set out in the Announcement.

 

The Remuneration Committee believes that these additional performance criteria more closely align the targets with the interests of Shareholders. 

 

The Remuneration Committee has also determined that the New Options would only be granted to members of the full-time executive management team and key employees. Therefore, the number of New Options that are proposed to be granted to Directors of the Company and persons closely associated with them ("PCAs") are as follows:

 

Director/PCA

No. of existing options currently held and to be surrendered

No. of New Options to be granted

Percentage of existing issued share capital of the Company represented by the New Options

Stuart McGregor (CEO)

218,500

3,676,461

3.00%

Rupert Hutton (CFO)

147,250

1,225,487

1.00%

David Guyatt (Chairman)

1,061,416

-

-

Simon Lee (NED)

147,250

-

-

Simon Hember (NED)

26,125

-

-

Catherine Jamieson

(wife of David Guyatt)

180,000

612,743

0.50%

 

The Board of Osirium welcomes the opportunity for engagement with Shareholders and would like to thank those Shareholders who provided feedback on the original proposals. Full details of the proposed amendments to the Plan are set out in the explanatory notes to the notice of AGM. Should the Plan Resolution not be passed at the AGM, the Company will not be able to make the proposed amendments to the Plan or grant the New Options. A further announcement will be made on conclusion of the AGM.

 

Definitions

 

Capitalised terms used in this announcement have the meanings given to them in the Announcement issued by the Company on 3 April 2023, unless otherwise defined herein.

 

Contacts:

Osirium Technologies plc

Tel: +44 (0)1183 242 444

Stuart McGregor, Chief Executive Officer

Rupert Hutton, Chief Financial Officer

Allenby Capital Limited (Nominated adviser and broker)

Tel: +44 (0)20 3328 5656

James Reeve / George Payne (Corporate Finance)

Tony Quirke (Sales and Corporate Broking)

Alma PR (Financial PR adviser)

Tel: +44 (0)20 3405 0205

Hilary Buchanan

osirium@almapr.co.uk

Kieran Breheny

Will Ellis Hancock

 

About Osirium Technologies Plc

 

Osirium Technologies plc (AIM: OSI) is a leading UK-based cybersecurity software vendor delivering Privileged Access Management (PAM), Privileged Endpoint Management (PEM) and Osirium Automation solutions that are uniquely simple to deploy and maintain.

 

With privileged credentials involved in over 80% of security breaches, customers rely on Osirium PAM's innovative technology to secure their critical infrastructure by controlling 3rd party access, protecting against insider threats, and demonstrating rigorous compliance. Osirium Automation delivers time and cost savings by automating complex, multi-system processes securely, allowing them to be delegated to Help Desk engineers or end-users and to free up specialist IT resources. The Osirium PEM solution balances security and productivity by removing risky local administrator rights from users, while at the same time allowing escalated privileges for specific applications.

 

Founded in 2008 and with its headquarters in Reading, UK, the Group was admitted to trading on AIM in April 2016. For further information please visit www.osirium.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKDLFFXZLEBBE
Date   Source Headline
3rd Apr 201811:58 amRNSHolding(s) in Company
3rd Apr 20187:00 amRNSHolding(s) in Company
27th Mar 20187:00 amRNSResults of General Meeting
26th Mar 20187:00 amRNSNotice of Final Results
6th Mar 20187:05 amRNSPlacing and Notice of General Meeting
28th Feb 20187:00 amRNSOsirium Announces Support for Microsoft Azure
21st Feb 20187:00 amRNSContract win
7th Feb 20187:00 amRNSOsirium Signs Progress Distribution
9th Jan 20187:00 amRNSTrading Update
23rd Nov 20177:00 amRNSContract win
9th Nov 20177:00 amRNSContract Win
1st Nov 20177:00 amRNSContract Win
25th Oct 20177:00 amRNSContract win
20th Oct 20177:00 amRNSTwo contract renewals with Think Money & M-Netics
12th Oct 20177:00 amRNSContract renewals
6th Oct 20172:28 pmRNSHolding(s) in Company
25th Sep 20177:00 amRNSInterim Results
21st Sep 201712:08 pmRNSHolding(s) in Company
5th Sep 20177:00 amRNSOsirium partners with EB2BCOM in Asia Pacific
16th Aug 20177:00 amRNSNotice of Interim Results
11th Aug 20177:00 amRNSChange of Nominated Adviser
14th Jul 20177:00 amRNSOsirium confirms DACH Distribution Partner
12th Jun 20177:00 amRNSOsirium extends European Presence
5th Jun 20177:00 amRNSOsirium named a 'Cool Vendor' by Gartner
1st Jun 20173:05 pmRNSResult of AGM
9th May 20177:00 amRNSAnnual Financial Report
3rd May 20177:00 amRNSFinal Results
21st Apr 20177:01 amRNSHolding(s) in Company
21st Apr 20177:00 amRNSHolding(s) in Company
20th Apr 201711:37 amRNSHolding(s) in Company
12th Apr 20177:00 amRNSNotice of Final Results
4th Apr 201711:52 amRNSHolding(s) in Company
16th Mar 20177:00 amRNSDistributor Appointed in Middle East & Nth Africa
2nd Mar 20177:00 amRNSOsirium Extends Global Footprint to Asia Pacific
6th Jan 20177:00 amRNSBusiness update
26th Sep 20162:31 pmRNSDirector/PDMR Shareholding
20th Sep 20167:00 amRNSDirectorate Change
13th Sep 20168:55 amRNSDirector/PDMR Shareholding
26th Aug 20167:00 amRNSContract Win
21st Jul 20167:00 amRNSInterim Results
10th May 20162:44 pmRNSHolding(s) in Company
27th Apr 20165:21 pmRNSHolding(s) in Company
19th Apr 20167:00 amRNSHolding(s) in Company
15th Apr 20167:00 amRNSAdmission to trading on AIM & First Day of Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.